ubrogepant 100 MG Oral Tablet

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

ubrogepant 100 MG Oral Tablet

100 MG · Oral Tablet · oral

A form of ubrogepant →

ubrogepant 100 MG Oral Tablet — Calcitonin gene-related peptide (CGRP) antagonists. Strength, form, class, interactions & more.

ubrogepant 100 MG Oral Tablet

Active ingredient

ubrogepant →

Classification

Calcitonin gene-related peptide (CGRP) antagonistsCalcitonin Gene-related Peptide Receptor Antagonist

Drug interactions

Ubrogepant has several drug interactions primarily involving CYP3A4 inhibitors and inducers, as well as BCRP and P-gp inhibitors.

  • majorstrong CYP3A4 inducers (e.g., phenytoin, barbiturates, rifampin, St. John’s Wort) — loss of ubrogepant efficacy is expected
  • majorstrong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin) — significant increase in exposure of ubrogepant
  • moderatemoderate CYP3A4 inhibitors (e.g., cyclosporine, ciprofloxacin, fluconazole, fluvoxamine, grapefruit juice) — increase in ubrogepant exposure
  • moderateBCRP and/or P-gp only inhibitors (e.g., quinidine, carvedilol, eltrombopag, curcumin) — may increase the exposure of ubrogepant

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →